ARCHIVES

In Brief: Blumberg, Comis, Skalka Named Fox Chase VPs; Howard Temin Appointed To NCAB

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006